Merck & Co., Inc. (MRK) stock declined over -0.19% intraday to trade at $90.87 a share on NYSE. The stock opened with a gain of 1.01% at $90.34 and touched an intraday high of $91.89, rising 0.31% against the last close of $90.59. The stock went to a low of $90.3 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue57.17 Billion
5Y Sales Change4.1%
Fiscal Year Ends2021-12-30
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Merck & Co., Inc. (NYSE: MRK) stock price is $90.87 as of the last check on Wednesday, August 17. During the trading session, MRK stock reached the peak price of $91.89 while $90.3 was the lowest point it dropped to.
The NYSE listed MRK is part of Pharmaceuticals industry that operates in the broader Health Care sector. Merck & Co. , Inc.
Mr. Kenneth C. Frazier
Mr. Robert M. Davis J.D.
Pres, CEO & Director
Ms. Caroline Litchfield
Exec. VP & CFO
Mr. Richard R. DeLuca Jr.
Exec. VP & Pres of Merck Animal Health
MRK stock traded closed the last session at $91.04, which is -$0.1700000000000017 or -0.18673110720562577% lower than its previous close of $90.59. MRK's current trading price is 28.42% lower than its 52-week high of $95.72 where as its distance from 52-week low of 70.89% is -4.89%.
Number of MRK employees currently stands at -. MRK operates from 2000 Galloping Hill Road, Kenilworth, NJ 07033, United States.
Official Webiste of $MRK is: https://www.merck.com
MRK stock volume for the day was 2,628,578 shares while in the previous session number of MRK shares traded was 5,215,640 . The average number of MRK shares traded daily for last 3 months was 10.83 Million.
The percentage change in MRK stock occurred in the recent session was -0.18673110720562577% while the dollar amount for the price change in MRK stock was -$0.1700000000000017.
In the recent session, the day high for MRK stock was $91.89 while the low for MRK stock touched on the day was $90.3.
The market value of MRK currently stands at 225.33 Billion with its latest stock price at $90.87 and 2.53 Billion of its shares outstanding.